NUCLEOSIDE TRANSPORTERS: CNTs AND ENTs - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 196

76. Jarvis SM, Thorn JA, Glue P. 1998. Ribavirin uptake by human erythrocytes and the
involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters. Br J Phar-
macol 123(8):1587-1592.
77. Clarke ML, Damaraju VL, Zhang J, Mowles D, Tackaberry T, Lang T, Smith KM, Young
JD, Tomkinson B, Cass CE. 2006. The role of human nucleoside transporters in cellular
uptake of 4 -thio- { beta } -D-arabinofuranosylcytosine and { beta } -D-arabinosylcytosine.
Mol Pharmacol 70(1):303-310.
78. Yao SY, Ng AM, Sundaram M, Cass CE, Baldwin SA, Young JD. 2001. Transport of
antiviral 3 -deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitroben-
zylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in
Xenopus oocytes. Mol Membr Biol 18(2):161-167.
79. Sundaram M, Yao SY, Ng AM, Griffiths M, Cass CE, Baldwin SA, Young JD. 1998.
Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1
and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs.
J Biol Chem 273(34):21519-21525.
80. Huang M, Wang Y, Cogut SB, Mitchell BS, Graves LM. 2003. Inhibition of nucleoside
transport by protein kinase inhibitors. J Pharmacol Exp Ther 304(2):753-760.
81. Carrier EJ, Auchampach JA, Hillard CJ. 2006. Inhibition of an equilibrative nucleoside
transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl
Acad SciUSA103(20):7895-7900.
82. Griffiths M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD, Baldwin SA. 1997. Molec-
ular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative
nucleoside transporter from human placenta. Biochem J 328(Pt 3):739-743.
83. Crawford CR, Patel DH, Naeve C, Belt JA. 1998. Cloning of the human equilibrative,
nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by
functional expression in a transport-deficient cell line. J Biol Chem 273(9):5288-5293.
84. Yao SY, Ng AM, Vickers MF, Sundaram M, Cass CE, Baldwin SA, Young JD. 2002.
Functional and molecular characterization of nucleobase transport by recombinant human
and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role
for the ENT2 helix 5-6 region in nucleobase translocation. J Biol Chem 277(28):24938-
24948.
85. Vickers MF, Kumar R, Visser F, Zhang J, Charania J, Raborn RT, Baldwin SA, Young JD,
Cass CE. 2002. Comparison of the interaction of uridine, cytidine, and other pyrimidine
nucleoside analogues with recombinant human equilibrative nucleoside transporter 2
(hENT2) produced in Saccharomyces cerevisiae . Biochem Cell Biol 80(5):639-644.
86. Hyde RJ, Cass CE, Young JD, Baldwin SA. 2001. The ENT family of eukaryote nucleoside
and nucleobase transporters: recent advances in the investigation of structure/function
relationships and the identification of novel isoforms. Mol Membr Biol 18(1):53-63.
87. Acimovic Y, Coe IR. 2002. Molecular evolution of the equilibrative nucleoside transporter
family: identification of novel family members in prokaryotes and eukaryotes. Mol Biol
Evol 19(12):2199-2210.
88. Stein A, Vaseduvan G, Carter NS, Ullman B, Landfear SM, Kavanaugh MP. 2003. Equi-
librative nucleoside transporter family members from Leishmania donovani are electro-
genic proton symporters. J Biol Chem 278(37):35127-35134.
89. Vickers MF, Zhang J, Visser F, Tackaberry T, Robins MJ, Nielsen LP, Nowak I, Bald-
win SA, Young JD, Cass CE. 2004. Uridine recognition motifs of human equilibrative